Related Experiment Video
Updated: Apr 19, 2026

RNA Next-Generation Sequencing and a Bioinformatics Pipeline to Identify Expressed LINE-1s at the Locus-Specific Level
Published on: May 19, 2019
Regulatory roles of LINE-1-encoded reverse transcriptase in cancer onset and progression
Abstract:
LINE-1 retrotransposons encode the reverse transcriptase (RT) enzyme, required for their own mobility, the expression of which is inhibited in differentiated tissues while being active in tumors. Experimental evidence indicate that the inhibition of LINE-1-derived RT restores differentiation in cancer cells, inhibits tumor progression and yields globally reprogrammed transcription profiles. Newly emerging data suggest that LINE-1-encoded RT modulates the biogenesis of miRNAs, by governing the balance between the production of regulatory double-stranded RNAs and RNA:DNA hybrid molecules, with a direct impact on global gene expression. Abnormally high RT activity unbalances the transcriptome in cancer cells, while RT inhibition restores "normal" miRNA profiles and their regulatory networks. This RT-dependent mechanism can target the myriad of transcripts - both coding and non-coding, sense and antisense - in eukaryotic transcriptomes, with a profound impact on cell fates. LINE-1-encoded RT emerges therefore as a key regulator of a previously unrecognized mechanism in tumorigenesis.
Insights
LINE-1 reverse transcriptase (RT) is active in tumors, driving cancer progression. Inhibiting this enzyme restores normal cell function and miRNA profiles, revealing a novel mechanism in tumorigenesis.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- LINE-1 retrotransposons encode reverse transcriptase (RT), crucial for their mobility.
- LINE-1 RT expression is typically inhibited in differentiated tissues but active in tumors.
- Abnormal LINE-1 RT activity is implicated in cancer cell transcriptome dysregulation.
Purpose of the Study:
- To investigate the role of LINE-1-encoded reverse transcriptase (RT) in cancer.
- To explore how LINE-1 RT activity impacts gene expression and microRNA (miRNA) biogenesis in tumors.
- To determine if inhibiting LINE-1 RT can restore normal cellular function and suppress tumor progression.
Main Methods:
- Experimental inhibition of LINE-1-derived reverse transcriptase (RT) in cancer cells.
- Analysis of global transcription profiles following RT inhibition.
- Assessment of miRNA biogenesis and regulatory networks.
- Evaluation of tumor progression and cell differentiation markers.
Main Results:
- Inhibition of LINE-1 RT restored differentiation in cancer cells.
- RT inhibition led to globally reprogrammed transcription profiles.
- LINE-1 RT was found to modulate miRNA biogenesis by affecting regulatory RNA production.
- RT inhibition normalized aberrant miRNA profiles and regulatory networks in cancer cells.
- LINE-1 RT activity was identified as a key regulator in tumorigenesis.
Conclusions:
- LINE-1-encoded reverse transcriptase (RT) plays a critical role in tumorigenesis through transcriptome and miRNA regulation.
- Inhibiting LINE-1 RT activity offers a potential therapeutic strategy by restoring normal cellular mechanisms.
- This study uncovers a previously unrecognized RT-dependent mechanism impacting cell fates in cancer.
Related Concept Videos
Mechanisms of Retrovirus-induced Cancers
Mechanisms of Retrovirus-induced Cancers
Non-LTR Retrotransposons
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

